Browse the complete record of transactions filed by 권용진, Directeur. Insider active across 2 companies, notably 명문제약. Cumulatively, 74 reports have been logged. Activity tracked since 30 April 2026. The latest transaction was disclosed on 30 April 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Declarations 74 total
● 상무 · Executives · 30 Apr 2026 (filed) · 명문제약 Share DART:20260430000426 Ideal exit: 25 Jan 2027 (T+270) ● Executives · 30 Apr 2026 (filed) · 명문제약 11,184 shares DART:20260430000394 Ideal exit: 25 Jan 2027 (T+270) ● 전무 · Executives · 30 Apr 2026 (filed) · 명문제약 Share DART:20260430000081 Ideal exit: 25 Jan 2027 (T+270) ● 상무 · Executives · 30 Apr 2026 (filed) · 명문제약 Share DART:20260430000104 Ideal exit: 25 Jan 2027 (T+270) ● 이사 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000311 Ideal exit: 24 Jan 2027 (T+270) ● 이사 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000283 Ideal exit: 24 Jan 2027 (T+270) ● 이사 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000321 Ideal exit: 24 Jan 2027 (T+270) ● 전무 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000532 Ideal exit: 24 Jan 2027 (T+270) ● 이사 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000316 Ideal exit: 24 Jan 2027 (T+270) ● 이사 · Executives · 31 Mar 2026 (filed) · 사이냅소프트 Share DART:20260331001874 ● 이사 · Executives · 31 Mar 2026 (filed) · 사이냅소프트 Share DART:20260331001463 ● Executives · 11 Mar 2026 (filed)
● Executives · 6 Mar 2026 (filed)
● 이사 · Executives · 10 Feb 2026 (filed) · 명문제약 Share DART:20260210000322 Ideal exit: 7 Nov 2026 (T+270) ● 이사 · Executives · 3 Feb 2026 (filed) · 명문제약 Share DART:20260203000117 Ideal exit: 31 Oct 2026 (T+270) ● 이사 · Executives · 18 Dec 2025 (filed) · 명문제약 Share DART:20251218000036 Ideal exit: 14 Sept 2026 (T+270) ● Executives · 6 Nov 2025 (filed)
● Executives · 10 Mar 2025 (filed)
● 이사 · Executives · 22 Nov 2024 (filed) · 사이냅소프트 Share DART:20241122000181 Ideal exit: 19 Aug 2025 (T+270) ● 이사 · Executives · 22 Nov 2024 (filed) · 사이냅소프트 Share DART:20241122000295 Ideal exit: 19 Aug 2025 (T+270) ● Executives · 17 Jan 2024 (filed)
● Executives · 23 Oct 2023 (filed) · 명문제약 116,303 shares DART:20231023000062 Ideal exit: 19 Jul 2024 (T+270) ● Executives · 12 Oct 2023 (filed) · 명문제약 116,303 shares DART:20231012000018 Ideal exit: 8 Jul 2024 (T+270) ● Executives · 25 Sept 2023 (filed) · 명문제약 116,303 shares DART:20230925000068 Ideal exit: 21 Jun 2024 (T+270) ● Executives · 11 Jul 2023 (filed) · 명문제약 116,303 shares DART:20230711000229 Ideal exit: 6 Apr 2024 (T+270) 25 of 74 declarations
Load more (49 remaining) About 권용진 Kwon Yong-jin is a Director at Myungmoon Pharmaceutical, where he is involved in managing operations and projects. His role is essential in ensuring the quality and efficiency of processes within the company. Myungmoon Pharmaceutical is an innovative firm in the pharmaceutical sector. Kwon Yong-jin contributes to achieving the company's strategic objectives.